Page last updated: 2024-08-21

fluorobenzenes and Acute Disease

fluorobenzenes has been researched along with Acute Disease in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abbott, CJ; Burgoyne, CF; Choe, TE; Fortune, B; Lusardi, TA; Wang, L1
Cho, SI; Gwag, BJ; Lee, HY; Lim, HR; Moon, GJ; Noh, JS; Park, EJ; Rao, RR; Springer, JE1
Alhashemi, J; Burns, KE; Chant, C; Cook, DJ; Cuthbertson, B; Dominguez-Cherit, G; Fowler, R; Kruger, P; Marshall, JC; Rubenfeld, GD; Smith, O; Webb, S; Zala, C1
Abo-Gresha, NM; Zaitone, SA1
Dolan, JG; Nautiyal, A; Singh, S1
Cannizzaro, S; Di Pasquale, P; Fasullo, S; Ganci, F; Giambanco, F; Marenghini, G; Paterna, S; Polizzi, G; Scalzo, S; Vitale, G1
Balkaya, M; Endres, M; Gertz, K; Kronenberg, G; Laufs, U; Leithner, C; Lindauer, U; Prinz, V1

Trials

2 trial(s) available for fluorobenzenes and Acute Disease

ArticleYear
A Canadian Critical Care Trials Group project in collaboration with the international forum for acute care trialists - Collaborative H1N1 Adjuvant Treatment pilot trial (CHAT): study protocol and design of a randomized controlled trial.
    Trials, 2011, Mar-09, Volume: 12

    Topics: Acute Disease; Anti-Inflammatory Agents; Antiviral Agents; Argentina; Australia; Canada; Cooperative Behavior; Critical Care; Critical Illness; Drug Therapy, Combination; Feasibility Studies; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Influenza A Virus, H1N1 Subtype; Influenza, Human; Informed Consent; Mexico; New Zealand; Patient Selection; Pilot Projects; Pyrimidines; Research Design; Respiration, Artificial; Rosuvastatin Calcium; Saudi Arabia; Sulfonamides; Treatment Outcome

2011
Combination of indomethacin and statin compared with indomethacin and placebo in patients with a first episode of acute pericarditis: preliminary findings.
    Clinical science (London, England : 1979), 2007, Volume: 113, Issue:11

    Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; C-Reactive Protein; Cardiovascular Agents; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indomethacin; Inflammation Mediators; Male; Pericarditis; Pyrimidines; Recurrence; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome

2007

Other Studies

5 other study(ies) available for fluorobenzenes and Acute Disease

ArticleYear
Evaluation of retinal nerve fiber layer thickness and axonal transport 1 and 2 weeks after 8 hours of acute intraocular pressure elevation in rats.
    Investigative ophthalmology & visual science, 2014, Feb-04, Volume: 55, Issue:2

    Topics: Acute Disease; Animals; Axonal Transport; Axons; Cell Count; Fluorescent Dyes; Fluorobenzenes; Intraocular Pressure; Male; Microglia; Ocular Hypertension; Ophthalmoscopy; Optic Nerve Diseases; Rats; Rats, Inbred BN; Retinal Ganglion Cells; Retinal Neurons; Time Factors; Tomography, Optical Coherence; Tonometry, Ocular

2014
The functional and neuroprotective actions of Neu2000, a dual-acting pharmacological agent, in the treatment of acute spinal cord injury.
    Journal of neurotrauma, 2010, Volume: 27, Issue:1

    Topics: Acute Disease; Animals; Antioxidants; Benzoates; Disease Models, Animal; Drug Administration Schedule; Female; Fluorobenzenes; Free Radicals; meta-Aminobenzoates; Mitochondria; Motor Activity; Neuroprotective Agents; Neurotoxins; Oxidative Stress; Rats; Rats, Long-Evans; Recovery of Function; Salicylates; Spinal Cord; Spinal Cord Injuries; Treatment Outcome

2010
Rosuvastatin promotes angiogenesis and reverses isoproterenol-induced acute myocardial infarction in rats: role of iNOS and VEGF.
    European journal of pharmacology, 2012, Sep-15, Volume: 691, Issue:1-3

    Topics: Acute Disease; Animals; Body Weight; Electrocardiography; Fluorobenzenes; Heart Ventricles; Isoproterenol; Male; Myocardial Infarction; Neovascularization, Physiologic; Nitric Oxide Synthase Type II; Organ Size; Pyrimidines; Rats; Rats, Wistar; Receptors, Complement 3b; Rosuvastatin Calcium; Sulfonamides; Survival Analysis; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A

2012
Recurrent acute pancreatitis possibly induced by atorvastatin and rosuvastatin. Is statin induced pancreatitis a class effect?
    JOP : Journal of the pancreas, 2004, Nov-10, Volume: 5, Issue:6

    Topics: Acute Disease; Aged; Atorvastatin; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pancreatitis; Pyrimidines; Pyrroles; Recurrence; Rosuvastatin Calcium; Sulfonamides

2004
Intravenous rosuvastatin for acute stroke treatment: an animal study.
    Stroke, 2008, Volume: 39, Issue:2

    Topics: Acute Disease; Animals; Aorta; Disease Models, Animal; Dose-Response Relationship, Drug; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infarction, Middle Cerebral Artery; Injections, Intravenous; Mice; Mice, Inbred Strains; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyrimidines; Recovery of Function; Reperfusion Injury; Rosuvastatin Calcium; Sulfonamides

2008